Organon & Co (OGN)
18.71
+0.19
(+1.03%)
USD |
NYSE |
Apr 24, 16:00
18.59
-0.12
(-0.64%)
After-Hours: 20:00
Organon Shareholders Equity (Quarterly): -70.00M for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -70.00M |
| September 30, 2023 | -589.00M |
| June 30, 2023 | -555.00M |
| March 31, 2023 | -737.00M |
| December 31, 2022 | -892.00M |
| September 30, 2022 | -1.066B |
| June 30, 2022 | -1.137B |
| Date | Value |
|---|---|
| March 31, 2022 | -1.25B |
| December 31, 2021 | -1.508B |
| September 30, 2021 | -1.618B |
| June 30, 2021 | -1.934B |
| March 31, 2021 | 4.722B |
| December 31, 2020 | 5.486B |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-1.934B
Minimum
Jun 2021
5.486B
Maximum
Dec 2020
-88.31M
Average
-892.00M
Median
Dec 2022
Shareholders Equity (Quarterly) Benchmarks
| Merck & Co Inc | 37.58B |
| Alnylam Pharmaceuticals Inc | -220.64M |
| Amgen Inc | 6.232B |
| Biogen Inc | 14.80B |
| Pacira BioSciences Inc | 870.13M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 12.06B |
| Total Liabilities (Quarterly) | 12.13B |
| Debt to Equity Ratio | -125.14 |
| Current Ratio | 1.545 |
| Net Debt Paydown Yield | -0.33% |